Skip to main content

Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease

Buy Article:

$43.00 plus tax (Refund Policy)

Mauri M, Mancioli A, Rebecchi V, Corbetta S, Colombo C, Bono G. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.

Acta Neurol Scand 2006: 114: 97–101. © 2006 The Authors Journal compilation © 2006 Blackwell Munksgaard. Objective – 

The aim of this article was to evaluate the effects of amisulpride on the behavioural and psychiatric symptoms of patients with Alzheimer's disease (AD). Materials and methods – 

In this open-label study, we observed 18 outpatients affected by moderate to severe AD, complicated with agitation and disruptive behaviours. Behavioural, cognitive and motor effects of amisulpride at baseline and after 12 weeks were rated by the Neuropsychiatric Inventory (NPI), Mini Mental State Examination, Clinical Dementia Rating Scale, activities of daily living, and the motor score of the Unified Parkinson's Disease Rating Scale. Results – 

After treatment with amisulpride (200 mg/day), the patients showed a significant decrease in NPI total scores, particularly for the subitem ‘agitation’. Cognitive and motor variables did not worsen significantly over the 12-week period. Conclusions – 

This preliminary observation suggests that amisulpride can be useful to control agitation and disruptive behaviours in AD patients without significantly effecting vigilance and motor activity.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Alzheimer's disease; agitation; amisulpride; disruptive behaviour

Document Type: Research Article

Affiliations: 1: Neurology 2: Pharmacology, Department of Clinical Medicine, Ospedale di Circolo – University of Insubria, Varese, Italy

Publication date: 2006-08-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more